General content related to arbovirology, with links to Coffey or Barker lab sites as relevant.
CDC Info on Zika
- Zika Cases in the United States
- Congenital Zika Syndrome and Other Birth Defects
- Clinical Considerations for Pregnant Women with Possible Zika Virus Infection | Zika Virus | CDC
- Testing for Zika
- Preventing Zika
- How Zika Spreads
- Zika Symptoms and Complications
- Protecting Workers from Zika
- Work outdoors? Protect yourself!
- Know before you go!
Zika virus Articles:
- Zika Virus Neutralizing Antibody Responses Elicited by Vaccination or Infection
- Comparing human pediatric immune responses to primary infection with dengue, chikungunya and Zika viruses
- Sec61 translocon inhibitor flavitransin blocks selectively dengue virus polyprotein insertion in the ER with pan-orthoflavivirus antiviral potency
- Analysis of the <em>Public Health Weekly Report</em> Papers Released during Public Health Crises
- Mosquito Surveillance at Airports and Seaports to Prevent and Control Emerging Mosquito-borne Diseases in Korea, 2023
- Mosquito Surveillance at Airports and Seaports to Prevent and Control Emerging Mosquito-borne Diseases in the Republic of Korea, 2024
- Virtual reality and cheminformatics-driven discovery of a potential broad-spectrum natural antagonist against flaviviral methyltransferases and its cytotoxicity evaluation
- Prenatal Exposure to Zika Virus and Risk of Epilepsy-Related Hospitalization During Early Childhood
- MARCH to combat Zika virus infection
- A comprehensive review redefining viruses as therapeutic agents in cancer treatment
Latest on Zika virus
- Zika Virus Neutralizing Antibody Responses Elicited by Vaccination or Infection
- Prenatal Exposure to Zika Virus and Risk of Epilepsy-Related Hospitalization During Early Childhood
- MARCH to combat Zika virus infection
- Zika Virus: A Tale of Two Lineages
- Correction: Agundis-Tinajero et al. Deep Learning-Based Automatic Segmentation and Analysis of Mitochondrial Damage by Zika Virus and SARS-CoV-2. Viruses 2025, 17, 1272
Latest on dengue virus
- Comparing human pediatric immune responses to primary infection with dengue, chikungunya and Zika viruses
- Adaptive Evolution of Dengue Virus: Interplay Between Viral Genetics and Host Immunity
- Dengue Fever: Viral, Environmental, and Human Factors Driving Expansion and Pandemic Risk
- Sec61 translocon inhibitor flavitransin blocks selectively dengue virus polyprotein insertion in the ER with pan-orthoflavivirus antiviral potency
- Epidemiology and severity risk factors of dengue virus infection during the 2023-2024 outbreak in Colombia